Theratechnologies Inc (THTX)
1.21
-0.01
(-0.82%)
USD |
NASDAQ |
Nov 14, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Theratechnologies Enterprise Value: 74.38M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 74.38M |
| November 12, 2024 | 76.54M |
| November 11, 2024 | 76.22M |
| November 08, 2024 | 76.22M |
| November 07, 2024 | 78.52M |
| November 06, 2024 | 77.14M |
| November 05, 2024 | 77.14M |
| November 04, 2024 | 73.00M |
| November 01, 2024 | 74.38M |
| October 31, 2024 | 73.92M |
| October 30, 2024 | 75.76M |
| October 29, 2024 | 74.82M |
| October 28, 2024 | 76.22M |
| October 25, 2024 | 74.84M |
| October 24, 2024 | 75.76M |
| October 23, 2024 | 77.14M |
| October 22, 2024 | 79.83M |
| October 21, 2024 | 80.82M |
| October 18, 2024 | 79.44M |
| October 17, 2024 | 77.14M |
| October 16, 2024 | 77.60M |
| October 15, 2024 | 78.06M |
| October 14, 2024 | 75.60M |
| October 11, 2024 | 75.99M |
| October 10, 2024 | 76.44M |
| Date | Value |
|---|---|
| October 09, 2024 | 74.38M |
| October 08, 2024 | 73.92M |
| October 07, 2024 | 74.84M |
| October 04, 2024 | 73.58M |
| October 03, 2024 | 73.79M |
| October 02, 2024 | 73.00M |
| October 01, 2024 | 73.92M |
| September 30, 2024 | 75.30M |
| September 27, 2024 | 75.76M |
| September 26, 2024 | 73.00M |
| September 25, 2024 | 72.54M |
| September 24, 2024 | 72.08M |
| September 23, 2024 | 75.53M |
| September 20, 2024 | 75.30M |
| September 19, 2024 | 74.38M |
| September 18, 2024 | 73.46M |
| September 17, 2024 | 81.28M |
| September 16, 2024 | 83.58M |
| September 13, 2024 | 80.36M |
| September 12, 2024 | 75.30M |
| September 11, 2024 | 74.84M |
| September 10, 2024 | 73.23M |
| September 09, 2024 | 74.84M |
| September 06, 2024 | 74.61M |
| September 05, 2024 | 75.07M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
56.53M
Minimum
Oct 30 2023
388.60M
Maximum
Sep 24 2021
194.75M
Average
203.80M
Median
Sep 16 2020
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 836.78M |
| Edesa Biotech Inc | 5.103M |
| Lexaria Bioscience Corp | 26.69M |
| InMed Pharmaceuticals Inc | -3.471M |
| Xenon Pharmaceuticals Inc | 2.455B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 3.091M |
| Revenue (Quarterly) | 22.60M |
| Total Expenses (Quarterly) | 16.39M |
| EPS Diluted (Quarterly) | 0.06 |
| Gross Profit Margin (Quarterly) | 80.00% |
| Profit Margin (Quarterly) | 13.68% |
| Earnings Yield | -4.13% |
| Operating Earnings Yield | 18.14% |
| Normalized Earnings Yield | -1.952 |